about
Therapeutic choices in the locomotor management of the child with cerebral palsy--more luck than judgement?Baclofen Protects Primary Rat Retinal Ganglion Cells from Chemical Hypoxia-Induced Apoptosis Through the Akt and PERK PathwaysHeterogeneity of muscle sizes in the lower limbs of children with cerebral palsy.Population pharmacokinetics of oral baclofen in pediatric patients with cerebral palsySpasticity management: an overview.Reliability of Ashworth and Modified Ashworth scales in children with spastic cerebral palsySpasticity in children with cerebral palsy: a retrospective review of the effects of intrathecal baclofen.Cerebellar ataxia and intrathecal baclofen therapy: Focus on patients´ experiences.Intrathecal baclofen for dystonia: benefits and complications during six years of experience.Current evidence for the use of botulinum toxin type A in the management of children with cerebral palsy: a systematic review.Botulinum toxin type A management of spasticity in the context of orthopaedic surgery for children with spastic cerebral palsy.Classification of gait patterns in spastic hemiplegia and spastic diplegia: a basis for a management algorithm.Management of spasticity with severe painful myoclonic jerks in an operated case of spinal astrocytoma.Treatment of spasticity with intrathecal Baclofen administration: long-term follow-up, review of 40 patients.Intrathecal baclofen pump for spasticity: an evidence-based analysis.A review of pediatric pain management in acute and chronic setting.Oral baclofen and clonidine for treatment of spasticity in children.Selective dorsal rhizotomy for spastic cerebral palsy: a review.A randomized, placebo-controlled trial of levetiracetam in central pain in multiple sclerosis.A method for reducing the pocket complications of the internal infusion pumps in pediatric patients: a case report.Intrathecal baclofen for the treatment of intractable spasticity of spine or brain etiology.Nutritional status of children with cerebral palsy in Turkey.Intrathecal baclofen in cerebral palsy movement disorders.Dexmedetomidine for acute baclofen withdrawal.Subfascial expansive plasty for intrathecal baclofen pump replacement. A technical note.Abrupt intrathecal baclofen withdrawal: management of potentially life-threatening sequelae.Reversible coma in children after improper baclofen pump insertion.Treatment of functional limitations at the knee in ambulatory children with cerebral palsy.Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.Limitations of intrathecal baclofen for spastic hemiparesis following stroke.Intrathecal baclofen therapy for spasticity of cerebral origin: cerebral palsy and brain injury.The silver jubilee: Journal of Child Neurology turns 25.Complicated negative pressure pulmonary oedema in a child with cerebral palsy.Intrathecal baclofen therapy: benefits and complications.
P2860
Q28359838-1763ADBA-63F9-4D39-903A-49201AE80883Q28822200-7D136694-C589-4509-93BB-2BC9EC234D79Q30278093-7FF1C78D-4CF9-45E3-A0AE-DD6CA5C46844Q30405534-B2390618-B973-492C-99B4-86CA406F115BQ32064742-00A443EE-DB9B-439C-8F35-406A6E1DD0D6Q33327601-FB556FF0-E4EE-444E-A771-28B550CF8238Q33585181-FA6FB749-90BF-46CB-BA95-3E89CC9AADD1Q33842317-D240EF5D-BAE7-4EEE-9B95-EF6144823D56Q34512130-2D228201-AF57-4384-B0DA-8B0F0DD9EA68Q34536042-9943422E-F5C7-4647-BC14-0D6C6483D941Q34536049-5D70825E-403C-494A-91D5-19BB4058B489Q34536055-B428EB9E-DA99-4BD3-A5AF-D515324EF7C2Q34975472-A0299D9D-5A7B-4B51-9D1D-F3E4D60125CBQ35859855-5D2E979A-E9D0-40CC-A991-D7239C05D839Q36056214-5D2AF1FF-8EDB-4BEA-B6FB-B32100D79278Q36674237-9A4C3269-2BA2-4D28-A22A-41E4F4F09641Q36677761-2E262DBD-A4FF-4D33-9B2E-C9B76FC31757Q36841571-345236D4-FEB8-4684-B435-55109BA3E8F8Q39251767-E1C3AB7D-6755-459C-B38D-00DD3EE8593EQ39408741-E5534B63-0B18-4083-8D25-776D40B7A1A1Q39431571-0511E43A-51F8-48DA-BC22-5C69BD71D33DQ40043535-DB83E8BB-1E0F-4727-88A2-A8D4B59A87B6Q41262367-3891FDAD-B6BB-4D41-9414-ADAB2535974BQ41658188-EF2BE642-C20E-4A56-B5A7-53056464E280Q42128112-96ABFD55-831F-43D4-B4AF-F3C0EC32ADC8Q42723046-43C7240C-C4B9-4235-84AA-2E668D68543CQ44024634-CF67D1F5-9412-48F6-BBEC-3225E0FE5B3CQ45711276-010F2ED0-78AC-4FCF-AC38-4EDAECD8B4B7Q46202704-CAC162C3-8454-4266-96F5-7B58335FF4E6Q46363706-60CE803E-314E-4B6C-934C-D72CA6DB80D1Q48249687-3D0DBE63-2E1C-444A-BD9C-1476E37AB738Q48924888-6A4F9F42-B089-4D51-8DFE-683CD712A957Q49161933-F6DEE892-DF13-4300-ACC2-B9C8F6F513AEQ51858090-A367937D-480E-4FCC-9E88-433852AF2004
P2860
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Baclofen in the treatment of cerebral palsy.
@en
Baclofen in the treatment of cerebral palsy.
@nl
type
label
Baclofen in the treatment of cerebral palsy.
@en
Baclofen in the treatment of cerebral palsy.
@nl
prefLabel
Baclofen in the treatment of cerebral palsy.
@en
Baclofen in the treatment of cerebral palsy.
@nl
P1476
Baclofen in the treatment of cerebral palsy.
@en
P2093
A L Albright
P356
10.1177/088307389601100202
P577
1996-03-01T00:00:00Z